Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Nature Reviews. Rheumatology|May 5, 2009
Assessing infection risk with biologic agents in RA: methodological challengesMark C Fisher, Jeffrey D Greenberg
The Journal of Rheumatology|March 17, 2012
Smoking, smoking cessation, and disease activity in a large cohort of patients with rheumatoid arthritisMark C Fisher, Marc C Hochberg, Muhammad El-Taha, et al.
BMC Musculoskeletal Disorders|June 2, 2012
Malignancy validation in a United States registry of rheumatoid arthritis patientsMark C Fisher, Victoria Furer, Marc C Hochberg, et al.
Bulletin of the NYU Hospital for Joint Diseases|June 22, 2007
Predicting response to TNF antagonists in rheumatoid arthritis: the promise of pharmacogenetics research using clinical registriesJeffrey D Greenberg, Harry Ostrer
Bulletin of the NYU Hospital for Joint Diseases|October 10, 2007
TNF antagonist safety in rheumatoid arthritis: updated evidence from observational registriesAdeel Nasir, Jeffrey D Greenberg
Nature Clinical Practice. Rheumatology|February 21, 2008
Are NSAIDs and selective cyclo-oxygenase 2 inhibitors associated with increased risk of myocardial infarction?Steven B Abramson, Jeffrey D Greenberg
Nature Reviews. Rheumatology|October 3, 2009
Dendritic cells as targets for therapy in rheumatoid arthritisShaukat Khan, Jeffrey D Greenberg, Nina Bhardwaj
Nature Reviews. Rheumatology|November 16, 2011
Cardiovascular safety of biologic therapies for the treatment of RAJeffrey D Greenberg, Victoria Furer, Michael E Farkouh
Current Opinion in Rheumatology|March 20, 2008
The role of drug and disease registries in rheumatic disease epidemiologyJoel M Kremer, Allan Gibofsky, Jeffrey D Greenberg
Pageof 14